Skip to main content
Premium Trial:

Request an Annual Quote

LifeLabs to Distribute Natera's Panorama NIPD in Canada

NEW YORK (GenomeWeb News) – Natera and LifeLabs Medical Laboratory Services today announced a deal to distribute the Panorama non-invasive prenatal diagnostic test in Canada.

Natera's test was launched in March for the detection of trisomy 21, 18, and 13 and some sex chromosome abnormalities. Last month, detection of triploidy was added to the test.

Financial and other terms of the deal were not disclosed.

"We continue to gain momentum with our global rollout by partnering with leading organizations, such as LifeLabs, and are glad to now expand into Canada," Natera CEO Matthew Rabinowitz said in a statement.

Last month, DASA Group and Natera reached a deal to offer Panorama in Brazil, and Natera inked a deal with Unilabs to bring the test to Switzerland and Scandinavia.

Last week, Illumina said it signed a supply agreement with Natera for Illumina's HiSeq 2500 next-generation sequencing platform and associated Illumina consumables.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.